about
Role of vascular smooth muscle cell in the inflammation of atherosclerosisCritical insights into cardiovascular disease from basic research on the oxidation of phospholipids: the γ-hydroxyalkenal phospholipid hypothesisDifferent cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathwaysMeasurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.Role of the immune system in hypertension: modulation by dietary antioxidants.Connexins in vascular physiology and pathology.Induction of CCR2-dependent macrophage accumulation by oxidized phospholipids in the air-pouch model of inflammation.A vascular biology network model focused on inflammatory processes to investigate atherogenesis and plaque instability.The Minnesota Grading System using fundus autofluorescence of eye bank eyes: a correlation to age-related macular degeneration (an AOS thesis).Total serum bilirubin does not affect vascular reactivity in patients with diabetesAre the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseasesSystems genetics analysis of gene-by-environment interactions in human cellsAnti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in miceHDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanismsAn epoxyisoprostane is a major regulator of endothelial cell function.Free radicals and antioxidants: updating a personal view.Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acidsStable isotope labeled 4-(dimethylamino)benzoic acid derivatives of glycerophosphoethanolamine lipids.Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high cholesterol diet: macrophage binding and activation.The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.Hypercholesterolemia and microvascular dysfunction: interventional strategies.Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G(*) apolipoprotein J peptide using solution NMR.Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems.Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids.NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activityEnhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasmaIsoprostane generation and function.Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.Identification of carbonylated lipids from different phospholipid classes by shotgun and LC-MS lipidomics.Phospholipid oxidation generates potent anti-inflammatory lipid mediators that mimic structurally related pro-resolving eicosanoids by activating Nrf2.Primary sclerosing cholangitis--the arteriosclerosis of the bile duct?Emerging applications for zebrafish as a model organism to study oxidative mechanisms and their roles in inflammation and vascular accumulation of oxidized lipidsOral amphipathic peptides as therapeutic agents.Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights.Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidantsHypercholesterolemia and in-vivo coronary plaque composition in patients with coronary artery disease: a virtual histology - intravascular ultrasound study.Aldehyde metabolism in the cardiovascular system.
P2860
Q26823875-871674E6-3813-4950-88D1-5C8F5B0D04FFQ26830841-D91100E6-6E18-4D71-B587-19F0B660D627Q28505513-1562C72E-AC8B-49F0-82BD-AEFA0FBEA470Q30248995-17ED8287-BE55-4602-B2E1-6640CAD31548Q30424339-2133DA81-F09A-4814-A1C0-862B56B76C25Q30437099-0D1190AB-0BDE-41D8-A8DD-974217A66D3AQ30438557-CDC94660-FEDB-41A5-9171-A56A554BBCF9Q30597305-06E6BAD7-1B1A-4FB1-9254-BAC061344902Q33416832-A9CA2759-FE08-4347-A4D0-2C74C05E17CFQ33430205-0E755B37-B8E7-4AD1-8BF0-2DE91E861823Q33442816-47E05DCE-8514-4948-9D32-20726B881FC2Q33633974-1E3761EF-DF78-4D6F-9FFA-8996716114DBQ33708619-943EACE4-A15D-4F17-A796-94F62A67998DQ33756077-ACB4F1DC-150A-45C0-9267-7A60CAD895B5Q33945091-FF2ABF1E-9934-4D50-8E67-FD9C8645862BQ33951327-1BBA3A47-58D2-4416-9955-B13BA3EBDE26Q34031638-F97E0247-8486-46A9-AB0E-5D2B5F9E633BQ34074329-937A1FCB-08C4-47B2-8DF8-A0F42AC23D4AQ34090859-BFE41689-76BD-46BF-A983-58A4246B4375Q34186521-CB102D3F-D30F-4A4A-9A71-7D873BFCC2EEQ34356918-9444CFEA-3B58-4A8D-BB94-E9F8072548C5Q34375542-0ABF89E5-1809-4911-B032-B4552D3D1FBBQ34384359-6EC621DD-F63D-45AF-BBB9-DE02BE1D1B10Q34556407-598E7EAB-30F5-4F50-934A-415AF0147172Q34592643-75F480DE-A399-4FB0-9954-4DC433532207Q35036420-5821E607-DAA2-4927-93CD-643E117E7A88Q35045146-CFDAF934-38F3-4836-B0FD-31E89F27E150Q35150059-3274D737-3015-43D1-8D09-BDD2DB28DC9DQ35212906-808BD1CE-04D6-4DFB-8C3F-542E3AD6A12EQ35332267-1280C332-19C2-4576-AE28-B54433BA156FQ35554080-ACBEA229-0332-4E2C-A4B1-9525A8B01C2BQ35564833-302968E4-BBA3-4DAB-A1B8-EC153773B146Q35577209-D13B288B-8A16-46C5-81CF-D4AD14DEE345Q35632527-9FEB1FA4-38E2-4E05-8619-E5009E87F2DCQ36252515-E4CAFF2D-ED02-4ED2-BD8B-A678FC8E147BQ36349636-EE1AE3E6-0084-4C10-9F34-5B5357E9F3CCQ36491992-435969A3-DEEF-4532-9A76-82BAA9BD9A5AQ36511677-30DEEC14-7C45-4658-8DF0-28E778031146Q36601907-1A737954-059C-4EF9-9DC3-02924E4175FFQ36716474-6695EB01-09B3-4293-927A-1C50CE9C5AF3
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
A role for oxidized phospholipids in atherosclerosis.
@en
A role for oxidized phospholipids in atherosclerosis.
@nl
type
label
A role for oxidized phospholipids in atherosclerosis.
@en
A role for oxidized phospholipids in atherosclerosis.
@nl
prefLabel
A role for oxidized phospholipids in atherosclerosis.
@en
A role for oxidized phospholipids in atherosclerosis.
@nl
P356
P1476
A role for oxidized phospholipids in atherosclerosis.
@en
P2093
Andrew D Watson
Judith A Berliner
P356
10.1056/NEJMP058118
P407
P577
2005-07-01T00:00:00Z